Defining the Clinical Trial Ancillary Supply Chain SINCE 2006.
Built on Experience. Driven by Purpose. Focused on the Future.
In our 20 year history, Ancillare has proudly…
Supported global Phase I–IV studies for pharmaceutical, biotech, and CRO partners · Built a vast, integrated global depot network · Expanded capabilities to meet evolving industry needs · Continued to define and advance the Clinical Trial Ancillary Supply Chain discipline itself.
Our growth reflects our commitment to innovation, partnership, and operational excellence.
Our Journey: 2006 → 2026
Ancillare, LP is founded in North Wales, PA
A new vision for ancillary supply chain excellence begins.
U.S. Department of Commerce Export Achievement Award
Recognized for expanding global reach and supporting international clinical trials.
Operational Enhancements Implemented
Invested in systems and process enhancements to support a growing sponsor base.
New headquarters opens in Horsham, PA
A major step forward as Ancillare begins establishing a global footprint.
Ancillare Europe opens in Milton Keynes, UK
Expanded regional support strengthens service to EMEA-based clinical trials.
The Ancillare Professional Team™ (APT) is launched
A dedicated team of internal experts across all departments, delivering each sponsor a single point of contact for a streamlined clinical trial supply strategy.
Strategic Depot established in Canada
The first of many global logistics hubs to come.
ANSUMS™ The Ancillare Supply Chain Management System is Introduced
A technology platform providing real-time visibility, streamlined resupply, and global reporting across clinical programs.
ESTEEM™ (Executing Shipments Through Effective Enrollment Monitoring) model deployed
A breakthrough in on-demand distribution, aligning shipments with actual site-level patient enrollment for greater efficiency and control.
Strategic Depots added in Argentina, Brazil, Israel, Mexico, South America, South Korea, and Ukraine
Rapid expansion enhances Ancillare’s global coverage and response capabilities.
A-TKO™ Launched First and Only End-to-End Clinical and Ancillary Supply Chain Model
A unified approach to ensure consistency, cost transparency, and quality throughout the full development lifecycle.
Strategic Depots Established in China, Japan, Panama, Russia, and Taiwan
Global infrastructure deepens with new hubs across Asia, Europe, and Latin America.
Ancillare Celebrates its 10th Anniversary
A decade of growth, innovation, and service excellence.
U.S. Secretary of Commerce Award for Excellence in Exports
National recognition for exceptional international trade performance.
CEO Names Ancillare the Marcum Innovator of the Year
Honored for advancing ancillary supply chain solutions across the industry.
1500 Clinical Trials Supported Globally
Operations span more than 100 countries, 80,000 clinical sites, and over 700,000 enrolled patients.
Global Clinical Operations Department Expands
Strengthened infrastructure enhances capacity for increasingly complex studies.
Medical Supply Team Established
Centralized oversight enhances the administration and delivery of clinical trial supplies for sponsor partners.
CSO Named Philadelphia Business Journal’s 40 Under 40
Honored for his impact, leadership, and contributions to advancing Ancillare’s mission and growth.
CEO named “Most Admired CEO” by Philadelphia Business Journal
Recognized for exceptional leadership and continued advancement of Ancillare’s global supply chain innovation.
CEO Recognized as an EY Entrepreneur of the Year Finalist
Industry accolades reflect continuing visionary leadership.
Enterprising Women of the Year Award
CEO honored for leadership and entrepreneurial excellence.
CEO Earns Doctorate in Business Administration
A milestone reinforcing executive expertise in clinical supply chain management.
Partnered on 15 COVID-19 Clinical Trials
Rapid response capabilities support urgent global research.
Won Multi-million Dollar Contracts with Top Pharmaceutical Companies
Marks a significant expansion in high-value partnerships across major pharmaceutical portfolios.
Launch of Ancillare Supply Closets
High-volume supplies stored for immediate sponsor access, including dedicated sponsor supply closets.
New Distribution Facility Opened in the Netherlands
Expands European presence with a state-of-the-art distribution hub, enhancing supply chain efficiency and global reach.
Receives Medical Device Establishment License in Canada
Authorized to distribute and manage medical devices in Canada, expanding North American capabilities.
Acquisition of European-based Company, NG B.V.
Expanded sourcing and export capabilities to include medicinal products, enhancing global clinical trial support.
Surpassed Support of More than 1500 Clinical Trials
Services now reach 80,000 clinical sites across more than 100 countries.
Creation of cGMP-compliant Kitting Room
Enhanced precision, quality, and compliance for kitted clinical supplies.
Cold Chain Management Services Further Enhanced
Elevated capabilities ensure product integrity from sourcing to reclamation.
Became Global Distributor of Dexcom G7 CGM for Clinical Trials
Strengthening support for metabolic, endocrine, and device-focused trials with seamless global distribution of Dexcom G7 and expanding Ancillare’s capabilities in wearable technology.
Surpassed Support of More than 4,000 Clinical Trials
Services now reach 200,000 clinical sites across more than 100 countries.
Trusted by the World’s Leading Life sciences Organizations
Delivering comprehensive clinical trial ancillary supply chain solutions to the industry’s top Sponsors and CROs.
Continuing Industry Leadership
Ancillare remains dedicated to driving the global standard for the Clinical Trial Ancillary Supply Chain for Phase I-I clinical trials.
Here’s to 20 years strong, and the future we are going to build together.
— Joanne Santomauro, Co-Founder & CEO
Looking Ahead: The Next Era of CTASC™
As clinical trials continue to evolve, Ancillare remains committed to leading the next era of Clinical Trial Ancillary Supply Chain excellence. Our focus is on strengthening the CTASC™ model, enhancing efficiency, and ensuring Sponsors are prepared for what comes next.
Get in touch to learn what the future will bring for Ancillare and for your clinical trials.
